The use of anti-digoxin antibodies is typically indicated in cases of life-threatening digoxin toxicity. This includes severe cardiac arrhythmias, hyperkalemia (elevated potassium levels), or if the patient has ingested a potentially lethal dose. Additionally, these antibodies are considered when the serum digoxin concentration is significantly elevated, although clinical symptoms remain the primary guide for treatment.
